TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis March 16, 1979